{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:51:43Z","timestamp":1772013103680,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:p><jats:bold>\n            Background:<\/jats:bold>\n          <jats:roman>This secondary analysis examined the impact of methadone initiated in prison on postrelease HIV risk behaviors. The parent study was a three\u2010group randomized clinical trial in which participants received drug abuse counseling in prison and were randomly assigned to: (1) passive referral to substance abuse treatment upon release; (2) guaranteed methadone treatment admission upon release; and (3) methadone in prison and guaranteed continuation of methadone upon release.<\/jats:roman><\/jats:p><jats:p><jats:bold>\n            Methods:<\/jats:bold> Participants were 211 adult males with preincarceration histories of opiate dependence. The AIDS Risk Assessment was administered at baseline (in prison) and at 1\u2010, 3\u2010, 6\u2010, and 12\u2010month postrelease. Data were analyzed for the entire sample (N = 211) as well as the subsamples who reported injecting drugs in the 30 days prior to incarceration (n = 131) and who reported having unprotected sex in that time frame (n = 144) using generalized linear mixed model on an intent\u2010to\u2010treat basis.<\/jats:p><jats:p><jats:bold>\n            Results:<\/jats:bold>\n          <jats:roman>There were no significant changes in sex\u2010 or drug\u2010risk by Condition over Time. There were significant Time and Condition main effects for the total sample as well as the injector subsample for drug\u2010risk behaviors. There were no significant Condition main effects for HIV sex\u2010risk behaviors, but there were significant Time main effects.<\/jats:roman><\/jats:p><jats:p><jats:bold>\n            Conclusions:<\/jats:bold> Methadone initiated in prison or immediately postrelease is associated with reduced HIV drug\u2010risk compared to counseling in prison without methadone and passive referral to treatment at release. Participation in several drug\u2010 and sex\u2010risk behaviors also showed significant declines during the postrelease time periods. (Am J Addict 2012;21:476\u2013487)<\/jats:p>","DOI":"10.1111\/j.1521-0391.2012.00250.x","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T19:22:59Z","timestamp":1344626579000},"page":"476-487","source":"Crossref","is-referenced-by-count":20,"title":["Postprison Release HIV\u2010Risk Behaviors in a Randomized Trial of Methadone Treatment for Prisoners"],"prefix":"10.1111","volume":"21","author":[{"given":"Monique E.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy W.","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.06.014"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16742-1"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2008.10400648"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.14.7.53.23865"},{"key":"e_1_2_5_6_2","volume-title":"HIV in prisons, 2000","author":"Maruschak L.","year":"2002"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1037\/e672982007-001"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-006-9041-x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-156"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7384.308"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/16066359609010754"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-009-9348-5"},{"key":"e_1_2_5_13_2","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick RP","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-010-9451-7"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9345157.x"},{"key":"e_1_2_5_16_2","first-page":"1049","article-title":"Human immunodeficiency virus seroconversion among intravenous drug users in\u2010 and out\u2010of\u2010treatment: An 18\u2010month prospective follow\u2010up","volume":"6","author":"Metzger DS","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.00287.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.11.008"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817efb6e"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.11.015"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/17449200600743396"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00187-X"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01050.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2009.03.002"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.08.006"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.05.022"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.002238.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0093854807309111"},{"key":"e_1_2_5_29_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th edn","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_5_30_2","first-page":"121","article-title":"Psychosocial correlates of AIDS\u2010risk drug use and sexual behaviors","volume":"5","author":"Simpson DD","year":"1993","journal-title":"AIDS Educ Prev"},{"key":"e_1_2_5_31_2","volume-title":"Third Annual Meeting of the National AIDS Demonstration Research (NADR) Project","author":"Simpson DD","year":"1991"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(94)90047-7"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(96)01235-5"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199602010-00012"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n04_07"},{"key":"e_1_2_5_36_2","volume-title":"SPSS Survival Manual (Third Edition)","author":"Pallant J.","year":"2007"},{"key":"e_1_2_5_37_2","first-page":"477","volume-title":"Alcohol Timeline Followback (TLFB). Handbook of Psychiatric Measures","author":"Sobell LC","year":"2000"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196906192802502"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-200056804"},{"key":"e_1_2_5_40_2","volume-title":"Careers of Opioid Users","author":"Maddux JF","year":"1981"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/bsl.2370090303"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa064115"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02081.x"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0b013e3181873784"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1081\/JA-120004162"},{"key":"e_1_2_5_46_2","volume-title":"The War on Drugs III","author":"Inciardi JA.","year":"2008"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1521-0391.2012.00250.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1521-0391.2012.00250.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T22:56:47Z","timestamp":1698793007000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1521-0391.2012.00250.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1521-0391.2012.00250.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1521-0391.2012.00250.x","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]}}}